Resistance Training and Sarcopenic Obesity Elderly Women
Launched by UNIVERSIDADE ESTADUAL DE LONDRINA · Dec 6, 2017
Trial Information
Current as of August 30, 2025
Completed
Keywords
ClinConnect Summary
To investigate the effects of resistance training (RT) program on body composition, functional capacity, inflammatory and oxidative stress biomarkers in sarcopenic obesity elderly women. This study is a randomized controlled trial. Thirty-seven sarcopenic obesity (SO) elderly women were randomly allocated into two groups: a training group (TG, n=18) or a non-exercising control group (CG, n=19). A supervised RT program was performed by TG for 12 weeks and CG did not perform any type of physical exercise during this period. Body composition (DXA), functional capacity \[(muscular strength, and...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 60 years old or more;
- • presented sarcopenic obesity SO \[which was defined by the simultaneous presence of sarcopenia and obesity (Batsis et al., 2015; Studenski et al., 2014), whereas women were considered sarcopenic if appendicular lean soft tissue (LST) \<15.02 kg, and obese if percentage of body fat ≥ 35% (Batsis et al., 2015)\];
- • physically independent;
- • free from cardiac or orthopedic dysfunction;
- • not receiving hormonal replacement and/or thyroid therapy;
- • not using equipment that would compromise the accomplishment of protocols and tests;
- • not performing any regular physical exercise more than once a week over the six months preceding the beginning of the investigation.
- Exclusion Criteria:
- • individuals with any metallic implant or artificial pacemaker, who had undergone surgery, who were unable to perform the tests and trainings;
- • volunteers who failed the medical examination for any reason;
- • refused or were unable to give consent.
About Universidade Estadual De Londrina
The Universidade Estadual de Londrina (UEL) is a reputable academic institution located in Brazil, renowned for its commitment to advancing research and education in the health sciences. As a clinical trial sponsor, UEL leverages its extensive expertise and resources to conduct innovative research aimed at improving patient outcomes and contributing to medical knowledge. The university fosters collaboration among multidisciplinary teams, ensuring rigorous adherence to ethical standards and regulatory guidelines. UEL's dedication to scientific excellence and community health positions it as a pivotal player in the landscape of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials